Skip to content
Sign in
Artwork for AtheroTalk
Health & FitnessMedicine

AtheroTalk

European Atherosclerosis Society

AtheroTalk is your go-to podcast for in-depth discussions on atherosclerosis and cardiovascular health. Join leading experts as they explore the latest research, breakthrough treatments, and real-world insights into preventing and managing heart disease. Whether you're a healthcare professional, researcher, or just passionate about heart health, AtheroTalk delivers valuable knowledge and practical tips straight from the experts. Tune in to stay informed and inspired about the future of cardiovascular care!
--------------------------
This podcast is proudly initiated by the EAS Young Fellows.

Play
Open in
  • 25 episodes
  • fortnightly
  • Avg 32 min
  • English

Episodes 25

NewestOldestLongest
All5Unplayed5In progress0Played0
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • S1 · E21
    Oct 30, 2025 · 31 min

    E21: 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias

    This episode explores the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias, highlighting key changes in cardiovascular risk assessment, LDL-C targets, Lp(a) interpretation, and lipid-lowering strategies. Listeners gain practical insights into how these updates impact everyday clinical decision-making and the future of dyslipidaemia management. ------------------------------------------------- Script-prep: Fotios Barkas, Maria Cherska Interviewer: Fotios Barkas, Maria Cherska

  • S1 · E20
    Oct 20, 2025 · 37 min

    E20: Bart van de Sluis

    We sit down with Prof. Bart van de Sluis, Professor of Molecular Genetics and Translational Biology at the University of Groningen (UMCG). His research unravels the molecular mechanisms that control lipid metabolism and endo-lysosomal cholesterol transport, key processes in cardiometabolic diseases such as fatty liver disease and atherosclerosis. Prof. van de Sluis leads a research group dedicated to understanding how receptor trafficking and inflammation are regulated, with a focus on the NF-κB signaling pathway. Using advanced cellular and mouse models, including CRISPR/Cas approaches, his team pushes the boundaries of molecular medicine. Beyond his research, he heads the Transgenic Mouse Clinic for Aging Research (CRISPR facility). Join us as we talk about his scientific journey, the challenges of translational research, and his vision for the future of molecular biology and cardiovascular science. ------------------------------------------------- Script-prep: Hana Bartuskova, Maria Giovanna Lupo, Sanne Maas, Tatyana Storozhenko Interviewer: Sanne Maas

  • S1 · E19
    Oct 3, 2025 · 35 min

    E19: Michael Shapiro

    This time, we interview Prof. Michael Shapiro, President of the American Association of Preventive Cardiology and Chair-Elect of the AHA Council on Lipidology, Lipoprotein, Metabolism & Thrombosis. We delve into his academic journey and explore his predictions for the future of our field. --------------------------------------------------- Script-prep: Azin Kheirkhah, Svetlana Stoica, Tatyana Storozhenko Interviewer: Svetlana Stoica

  • S1 · E18
    Sep 20, 2025 · 44 min

    E18: EAS Paediatric Lipid Working Group

    Tune in to this special FH Awareness Week episode of our podcast featuring Prof. Steve Humphries. In this conversation, he shares valuable insights into familial hypercholesterolaemia (FH) and introduces the newly established EAS Paediatric Lipid Working Group. He highlights the importance of early detection, collaboration, and awareness to improve care and outcomes for children living with inherited lipid disorders. --------------------------------------------------- Script-prep: Hana Bartuskova, Joana Rita Chora, Laura Gaita, Azin Kheirkhah Interviewer: Azin Kheirkhah

  • S1 · E17
    Sep 11, 2025 · 31 min

    E17: EAS Consensus Statement on Systemic Metabolic Disorders

    Rates of obesity and related metabolic disorders have risen dramatically worldwide, yet most treatment strategies still focus on individual conditions, missing the bigger picture. A new Consensus Statement from the European Atherosclerosis Society introduces a holistic, clinically actionable framework that reflects disease progression across three stages, from early metabolic changes to advanced organ damage. In this episode, we discuss this new staging system in detail in an interview with the lead author, and we also hear from two EAS Young Fellows who worked behind the scenes, offering unique insights that go beyond what is published in the manuscript. --------------------------------------------------- Script-prep: Mariia Cherska, Azin Kheirkhah, Elena Rodriguez Sanchez Interviewer: Azin Kheirkhah, Elena Rodriguez Sanchez

Showing 21–25 of 25 episodes